Funder: The Cure Starts Now Foundation
Due Dates (Anticipated): June 2027 (Annual submission deadline)
Funding Amounts: Up to $100,000 USD; up to $200,000 USD for researchers at hospitals actively contributing to designated DIPG/DMG registries
Summary: Supports basic, translational, clinical, and delivery research toward a cure for all cancers, starting with pediatric brain cancer.
Key Information: Applicants must hold an MD, DO, PhD, DrPH, or equivalent degree and have an eligible organizational affiliation.
Description
The Homerun Grant is one of The Cure Starts Now Foundation’s classic grants, supporting basic, translational, clinical, and delivery research. It is designed as a broad funding opportunity within the foundation’s “homerun cure” strategy: pursuing a cure for all cancers by starting with pediatric brain cancer. Projects receive funding through either the foundation or the DIPG/DMG Collaborative, depending on funding availability and the research concentration of the proposal.
The foundation’s core research priorities are diffuse intrinsic pontine glioma (DIPG), diffuse midline glioma (DMG), and medulloblastoma. It also has a history of supporting other pediatric brain tumor research that contributes to its mission. The Homerun Grant is open to international applicants and industry partners.
